Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2021
Sensient Technologies Corporation (NYSE: SXT) reported a consolidated revenue of $340.4 million for Q4 2021, marking a 1.7% increase compared to Q4 2020. The company achieved a diluted earnings per share of 65 cents, up from 59 cents in the previous year. The Flavors & Extracts Group saw a 6.1% revenue decrease primarily due to divesting Fragrances, whereas Color and Asia Pacific groups reported double-digit revenue and profit growth. For 2022, Sensient anticipates mid-teen growth in GAAP diluted EPS and mid-single-digit growth in local currency revenue.
- Consolidated revenue increased by 1.7% to $340.4 million.
- Diluted earnings per share rose to 65 cents, a 10.2% increase year-over-year.
- Color Group revenue grew by 14.4%, driven by strong volume growth.
- Asia Pacific Group revenue increased by 11.1%, indicating robust performance.
- Flavors & Extracts Group revenue declined by 6.1%, primarily due to the divestiture of the Fragrances product line.
- Foreign currency translation negatively impacted revenue by approximately 1% and earnings per share by 2%.
Reported Consolidated Revenue Growth of
Adjusted Consolidated Local Currency Revenue Growth of
Flavors & Extracts Continues its Strong Performance
Color and Asia Pacific Groups Report Double Digit Revenue and Profit Growth
The 2021 fourth quarter reported results include divestiture & other related costs and operational improvement plan costs, which in total decreased fourth quarter net earnings by
BUSINESS REVIEW |
||||
Reported | ||||
Revenue | Quarter | Year-to-Date | ||
Flavors & Extracts |
- |
- |
||
Color |
|
|
||
|
|
|||
Total Revenue |
|
|
||
Adjusted | ||||
Local Currency (1) | ||||
Revenue | Quarter | Year-to-Date | ||
Flavors & Extracts |
|
|
||
Color |
|
|
||
|
|
|||
Total Revenue |
|
|
||
(1) Adjusted local currency percentage changes are described in more detail in the "Reconciliation of Non-GAAP Amounts" at the end of this release. |
Corporate & Other reported operating costs of
2022 OUTLOOK
The Company expects 2022 local currency revenue to grow at a mid-single-digit rate compared to the Company’s 2021 adjusted revenue(2). The Company expects 2022 local currency adjusted EBITDA(2) and local currency diluted earnings per share to grow at a high single-digit rate compared to the Company’s 2021 adjusted EBITDA(2) and the Company’s 2021 adjusted diluted earnings per share(2) of
The Company expects earnings per share reported on a
The Company’s guidance is based upon current trends, current tax law, and the effects of COVID-19 to date. The full impacts of the ongoing COVID-19 pandemic remain uncertain and management will continue to monitor its impacts on our business.
(2)See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information.
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include, currency movements, depreciation and amortization, non-cash share-based compensation, divestiture & other related costs, operational improvement plan costs and income, the 2020 COVID-19 employee payment costs, and the results of the divested operations. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2021 fourth quarter financial results at
A replay of the call will be available one hour after the end of the conference call through
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2022 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation, governmental regulations and restrictions, and general economic conditions, including inflation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended
ABOUT
|
||||||||||||||||||||
(In thousands, except percentages and per share amounts) |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|||||||||||||||||||
Consolidated Statements of Earnings |
Three Months Ended |
Year Ended |
||||||||||||||||||
|
|
|||||||||||||||||||
2021 |
|
2020 |
|
% Change |
|
2021 |
|
2020 |
|
% Change |
||||||||||
|
|
|||||||||||||||||||
Revenue | $ |
340,448 |
|
$ |
334,668 |
|
|
$ |
1,380,264 |
|
$ |
1,332,001 |
|
|
||||||
|
|
|||||||||||||||||||
Cost of products sold |
|
228,065 |
|
|
230,674 |
|
( |
|
925,603 |
|
|
908,254 |
|
|
||||||
Selling and administrative expenses |
|
71,963 |
|
|
69,179 |
|
|
|
284,633 |
|
|
271,091 |
|
|
||||||
|
|
|||||||||||||||||||
Operating income |
|
40,420 |
|
|
34,815 |
|
|
|
170,028 |
|
|
152,656 |
|
|
||||||
Interest expense |
|
2,752 |
|
|
3,399 |
|
|
|
12,544 |
|
|
14,811 |
|
|
||||||
|
|
|||||||||||||||||||
Earnings before income taxes |
|
37,668 |
|
|
31,416 |
|
|
|
157,484 |
|
|
137,845 |
|
|
||||||
Income taxes |
|
10,439 |
|
|
6,247 |
|
|
|
38,739 |
|
|
28,373 |
|
|
||||||
|
|
|||||||||||||||||||
Net earnings | $ |
27,229 |
|
$ |
25,169 |
|
|
$ |
118,745 |
|
$ |
109,472 |
|
|
||||||
|
|
|||||||||||||||||||
Earnings per share of common stock: |
|
|
||||||||||||||||||
Basic | $ |
0.65 |
|
$ |
0.59 |
|
|
$ |
2.82 |
|
$ |
2.59 |
|
|
||||||
|
|
|||||||||||||||||||
Diluted | $ |
0.65 |
|
$ |
0.59 |
|
|
$ |
2.81 |
|
$ |
2.59 |
|
|
||||||
|
|
|||||||||||||||||||
Average common shares outstanding: |
|
|
||||||||||||||||||
Basic |
|
41,890 |
|
|
42,307 |
|
|
|
42,077 |
|
|
42,301 |
|
|
||||||
|
|
|||||||||||||||||||
Diluted |
|
42,173 |
|
|
42,404 |
|
|
|
42,258 |
|
|
42,346 |
|
|
||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
Results by Segment |
Three Months Ended |
|
Year Ended |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue |
2021 |
|
2020 |
|
% Change |
|
2021 |
|
2020 |
|
% Change |
|||||||||
|
|
|||||||||||||||||||
Flavors & Extracts | $ |
177,448 |
|
$ |
189,060 |
|
( |
$ |
739,427 |
|
$ |
742,035 |
|
( |
||||||
Color |
|
137,104 |
|
|
119,813 |
|
|
|
545,270 |
|
|
501,018 |
|
|
||||||
|
35,749 |
|
|
32,165 |
|
|
|
135,348 |
|
|
121,227 |
|
|
|||||||
Intersegment elimination |
|
(9,853 |
) |
|
(6,370 |
) |
|
|
(39,781 |
) |
|
(32,279 |
) |
|
||||||
|
|
|||||||||||||||||||
Consolidated | $ |
340,448 |
|
$ |
334,668 |
|
|
$ |
1,380,264 |
|
$ |
1,332,001 |
|
|
||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
Operating Income |
|
|
||||||||||||||||||
|
|
|||||||||||||||||||
Flavors & Extracts | $ |
21,942 |
|
$ |
23,507 |
|
( |
$ |
98,660 |
|
$ |
90,974 |
|
|
||||||
Color |
|
24,113 |
|
|
20,548 |
|
|
|
103,575 |
|
|
96,034 |
|
|
||||||
|
7,184 |
|
|
6,044 |
|
|
|
26,330 |
|
|
22,075 |
|
|
|||||||
Corporate & Other |
|
(12,819 |
) |
|
(15,284 |
) |
|
|
(58,537 |
) |
|
(56,427 |
) |
|
||||||
|
|
|||||||||||||||||||
Consolidated | $ |
40,420 |
|
$ |
34,815 |
|
|
$ |
170,028 |
|
$ |
152,656 |
|
|
(In thousands) | ||||||
(Unaudited) | ||||||
Consolidated Condensed Balance Sheets |
|
|
|
|||
2021 |
|
2020 |
||||
Cash and cash equivalents | $ |
25,740 |
$ |
24,770 |
||
Trade accounts receivable |
|
261,121 |
|
234,132 |
||
Inventories |
|
411,635 |
|
381,346 |
||
Prepaid expenses and other current assets |
|
42,657 |
|
48,578 |
||
Assets held for sale |
|
- |
|
52,760 |
||
Total Current Assets |
|
741,153 |
|
741,586 |
||
|
435,009 |
|
434,220 |
|||
Property, plant, and equipment (net) |
|
446,478 |
|
445,493 |
||
Other assets |
|
122,853 |
|
119,561 |
||
Total Assets | $ |
1,745,493 |
$ |
1,740,860 |
||
Trade accounts payable | $ |
125,519 |
$ |
107,324 |
||
Short-term borrowings |
|
8,539 |
|
9,247 |
||
Other current liabilities |
|
98,247 |
|
82,045 |
||
Liabilities held for sale |
|
- |
|
17,339 |
||
Total Current Liabilities |
|
232,305 |
|
215,955 |
||
Long-term debt |
|
503,006 |
|
518,004 |
||
Accrued employee and retiree benefits |
|
28,579 |
|
28,941 |
||
Other liabilities |
|
43,178 |
|
43,624 |
||
Shareholders' Equity |
|
938,425 |
|
934,336 |
||
Total Liabilities and Shareholders' Equity | $ |
1,745,493 |
$ |
1,740,860 |
||
(In thousands, except per share amounts) | ||||||||
(Unaudited) | ||||||||
Consolidated Statements of Cash Flows | ||||||||
Year Ended |
||||||||
2021 |
|
2020 |
||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ |
118,745 |
|
$ |
109,472 |
|
||
Adjustments to arrive at net cash provided by operating activities: | ||||||||
Depreciation and amortization |
|
52,051 |
|
|
49,641 |
|
||
Share-based compensation expense |
|
9,573 |
|
|
5,608 |
|
||
Net loss (gain) on assets |
|
331 |
|
|
(252 |
) |
||
Loss on divestitures and other charges |
|
14,021 |
|
|
6,904 |
|
||
Deferred income taxes |
|
(6,071 |
) |
|
(8,705 |
) |
||
Changes in operating assets and liabilities: | ||||||||
Trade accounts receivable |
|
(34,571 |
) |
|
(11,357 |
) |
||
Inventories |
|
(36,323 |
) |
|
46,828 |
|
||
Prepaid expenses and other assets |
|
(6,057 |
) |
|
(12,868 |
) |
||
Trade accounts payable and other accrued expenses |
|
21,326 |
|
|
15,524 |
|
||
Accrued salaries, wages, and withholdings from employees |
|
7,321 |
|
|
15,140 |
|
||
Income taxes |
|
4,275 |
|
|
22 |
|
||
Other liabilities |
|
597 |
|
|
2,823 |
|
||
Net cash provided by operating activities |
|
145,218 |
|
|
218,780 |
|
||
Cash flows from investing activities: | ||||||||
Acquisition of property, plant, and equipment |
|
(60,788 |
) |
|
(52,162 |
) |
||
Proceeds from sale of assets |
|
216 |
|
|
1,075 |
|
||
Proceeds from divestiture of businesses |
|
37,790 |
|
|
12,595 |
|
||
Acquisition of new business |
|
(13,875 |
) |
|
- |
|
||
Other investing activities |
|
1,097 |
|
|
5,071 |
|
||
Net cash used in investing activities |
|
(35,560 |
) |
|
(33,421 |
) |
||
Cash flows from financing activities: | ||||||||
Proceeds from additional borrowings |
|
112,194 |
|
|
36,667 |
|
||
Debt payments |
|
(110,168 |
) |
|
(154,348 |
) |
||
Purchase of treasury stock |
|
(42,511 |
) |
|
- |
|
||
Dividends paid |
|
(66,694 |
) |
|
(66,057 |
) |
||
Other financing activities |
|
(582 |
) |
|
(415 |
) |
||
Net cash used in financing activities |
|
(107,761 |
) |
|
(184,153 |
) |
||
Effect of exchange rate changes on cash and cash equivalents |
|
(927 |
) |
|
2,411 |
|
||
Net increase in cash and cash equivalents |
|
970 |
|
|
3,617 |
|
||
Cash and cash equivalents at beginning of period |
|
24,770 |
|
|
21,153 |
|
||
Cash and cash equivalents at end of period | $ |
25,740 |
|
$ |
24,770 |
|
||
Supplemental Information | ||||||||
Year Ended |
|
2021 |
|
|
2020 |
|
||
Dividends paid per share | $ |
1.58 |
|
$ |
1.56 |
|
(In thousands, except percentages and per share amounts) | ||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
Reconciliation of Non-GAAP Amounts |
||||||||||||||||||||
The Company's results for the three and twelve months ended |
||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
|||||||||||||||
Revenue (GAAP) | $ |
340,448 |
|
$ |
334,668 |
|
|
$ |
1,380,264 |
|
$ |
1,332,001 |
|
|
||||||
Revenue of the divested product lines |
|
(663 |
) |
|
(25,163 |
) |
|
|
(30,062 |
) |
|
(113,553 |
) |
|
||||||
Adjusted revenue | $ |
339,785 |
|
$ |
309,505 |
|
|
$ |
1,350,202 |
|
$ |
1,218,448 |
|
|
||||||
|
|
|||||||||||||||||||
Operating income (GAAP) | $ |
40,420 |
|
$ |
34,815 |
|
|
$ |
170,028 |
|
$ |
152,656 |
|
|
||||||
Divestiture & other related costs – Cost of products sold |
|
58 |
|
|
4 |
|
|
|
86 |
|
|
1,795 |
|
|
||||||
Divestiture & other related costs – Selling and administrative expenses |
|
579 |
|
|
1,671 |
|
|
|
14,052 |
|
|
10,360 |
|
|
||||||
Operating loss (income) of the divested product lines |
|
518 |
|
|
(3,415 |
) |
|
|
(1,880 |
) |
|
(7,580 |
) |
|
||||||
Operational improvement plan - Cost of products sold |
|
- |
|
|
- |
|
|
|
- |
|
|
35 |
|
|
||||||
Operational improvement plan - Selling and administrative expenses (income) |
|
115 |
|
|
698 |
|
|
|
(1,895 |
) |
|
3,304 |
|
|
||||||
COVID-19 employee payment - Cost of products sold |
|
- |
|
|
1,036 |
|
|
|
- |
|
|
1,036 |
|
|
||||||
COVID-19 employee payment - Selling and administrative expenses |
|
- |
|
|
1,986 |
|
|
|
- |
|
|
1,986 |
|
|
||||||
Adjusted operating income | $ |
41,690 |
|
$ |
36,795 |
|
|
$ |
180,391 |
|
$ |
163,592 |
|
|
||||||
|
|
|||||||||||||||||||
Net earnings (GAAP) | $ |
27,229 |
|
$ |
25,169 |
|
|
$ |
118,745 |
|
$ |
109,472 |
|
|
||||||
Divestiture & other related costs, before tax |
|
637 |
|
|
1,675 |
|
|
|
14,138 |
|
|
12,155 |
|
|
||||||
Tax impact of divestiture & other related costs |
|
1,809 |
|
|
(1,393 |
) |
|
|
2,092 |
|
|
(2,605 |
) |
|
||||||
Net loss (earnings) of the divested product lines, before tax |
|
518 |
|
|
(3,415 |
) |
|
|
(1,880 |
) |
|
(7,580 |
) |
|
||||||
Tax impact of the divested product lines |
|
(130 |
) |
|
790 |
|
|
|
460 |
|
|
1,945 |
|
|
||||||
Operational improvement plan costs (income), before tax |
|
115 |
|
|
698 |
|
|
|
(1,895 |
) |
|
3,339 |
|
|
||||||
Tax impact of operational improvement plan |
|
427 |
|
|
(170 |
) |
|
|
471 |
|
|
(826 |
) |
|
||||||
COVID-19 employee payment, before tax |
|
- |
|
|
3,022 |
|
|
|
- |
|
|
3,022 |
|
|
||||||
Tax impact of COVID-19 employee payment |
|
- |
|
|
(675 |
) |
|
|
- |
|
|
(675 |
) |
|
||||||
Adjusted net earnings | $ |
30,605 |
|
$ |
25,701 |
|
|
$ |
132,131 |
|
$ |
118,247 |
|
|
||||||
|
|
|||||||||||||||||||
Diluted earnings per share (GAAP) | $ |
0.65 |
|
$ |
0.59 |
|
|
$ |
2.81 |
|
$ |
2.59 |
|
|
||||||
Divestiture & other related costs, net of tax |
|
0.06 |
|
|
0.01 |
|
|
|
0.38 |
|
|
0.23 |
|
|
||||||
Results of operations of the divested product lines, net of tax |
|
0.01 |
|
|
(0.06 |
) |
|
|
(0.03 |
) |
|
(0.13 |
) |
|
||||||
Operational improvement plan costs (income), net of tax |
|
0.01 |
|
|
0.01 |
|
|
|
(0.03 |
) |
|
0.06 |
|
|
||||||
COVID-19 employee payment, net of tax |
|
- |
|
|
0.06 |
|
|
|
- |
|
|
0.06 |
|
|
||||||
Adjusted diluted earnings per share | $ |
0.73 |
|
$ |
0.61 |
|
|
$ |
3.13 |
|
$ |
2.79 |
|
|
||||||
Note: Earnings per share calculations may not foot due to rounding differences. |
(In thousands) | ||||||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||||||
Reconciliation of Non-GAAP Amounts - Continued |
||||||||||||||||||||||||
Results by Segment |
Three Months Ended |
|||||||||||||||||||||||
|
|
|
|
Adjusted |
|
|
|
|
|
Adjusted |
||||||||||||||
Revenue |
2021 |
|
Adjustments (1) |
|
2021 |
|
2020 |
|
Adjustments (1) |
|
2020 |
|||||||||||||
Flavors & Extracts | $ |
177,448 |
|
$ |
(221 |
) |
$ |
177,227 |
|
$ |
189,060 |
|
$ |
(24,378 |
) |
$ |
164,682 |
|
||||||
Color |
|
137,104 |
|
|
(442 |
) |
|
136,662 |
|
|
119,813 |
|
|
(766 |
) |
|
119,047 |
|
||||||
|
35,749 |
|
|
- |
|
|
35,749 |
|
|
32,165 |
|
|
(116 |
) |
|
32,049 |
|
|||||||
Intersegment elimination |
|
(9,853 |
) |
|
- |
|
|
(9,853 |
) |
|
(6,370 |
) |
|
97 |
|
|
(6,273 |
) |
||||||
Consolidated | $ |
340,448 |
|
$ |
(663 |
) |
$ |
339,785 |
|
$ |
334,668 |
|
$ |
(25,163 |
) |
$ |
309,505 |
|
||||||
Operating Income | ||||||||||||||||||||||||
Flavors & Extracts | $ |
21,942 |
|
$ |
491 |
|
$ |
22,433 |
|
$ |
23,507 |
|
$ |
(3,214 |
) |
$ |
20,293 |
|
||||||
Color |
|
24,113 |
|
|
27 |
|
|
24,140 |
|
|
20,548 |
|
|
(158 |
) |
|
20,390 |
|
||||||
|
7,184 |
|
|
- |
|
|
7,184 |
|
|
6,044 |
|
|
(43 |
) |
|
6,001 |
|
|||||||
Corporate & Other |
|
(12,819 |
) |
|
752 |
|
|
(12,067 |
) |
|
(15,284 |
) |
|
5,395 |
|
|
(9,889 |
) |
||||||
Consolidated | $ |
40,420 |
|
$ |
1,270 |
|
$ |
41,690 |
|
$ |
34,815 |
|
$ |
1,980 |
|
$ |
36,795 |
|
||||||
Results by Segment |
Year Ended |
|||||||||||||||||||||||
|
|
|
|
Adjusted |
|
|
|
|
|
Adjusted |
||||||||||||||
Revenue |
2021 |
|
Adjustments (1) |
|
2021 |
|
2020 |
|
Adjustments (1) |
|
2020 |
|||||||||||||
Flavors & Extracts | $ |
739,427 |
|
$ |
(27,837 |
) |
$ |
711,590 |
|
$ |
742,035 |
|
$ |
(99,543 |
) |
$ |
642,492 |
|
||||||
Color |
|
545,270 |
|
|
(2,080 |
) |
|
543,190 |
|
|
501,018 |
|
|
(14,008 |
) |
|
487,010 |
|
||||||
|
135,348 |
|
|
(295 |
) |
|
135,053 |
|
|
121,227 |
|
|
(518 |
) |
|
120,709 |
|
|||||||
Intersegment elimination |
|
(39,781 |
) |
|
150 |
|
|
(39,631 |
) |
|
(32,279 |
) |
|
516 |
|
|
(31,763 |
) |
||||||
Consolidated | $ |
1,380,264 |
|
$ |
(30,062 |
) |
$ |
1,350,202 |
|
$ |
1,332,001 |
|
$ |
(113,553 |
) |
$ |
1,218,448 |
|
||||||
Operating Income | ||||||||||||||||||||||||
Flavors & Extracts | $ |
98,660 |
|
$ |
(2,368 |
) |
$ |
96,292 |
|
$ |
90,974 |
|
$ |
(8,292 |
) |
$ |
82,682 |
|
||||||
Color |
|
103,575 |
|
|
575 |
|
|
104,150 |
|
|
96,034 |
|
|
871 |
|
|
96,905 |
|
||||||
|
26,330 |
|
|
(87 |
) |
|
26,243 |
|
|
22,075 |
|
|
(159 |
) |
|
21,916 |
|
|||||||
Corporate & Other |
|
(58,537 |
) |
|
12,243 |
|
|
(46,294 |
) |
|
(56,427 |
) |
|
18,516 |
|
|
(37,911 |
) |
||||||
Consolidated | $ |
170,028 |
|
$ |
10,363 |
|
$ |
180,391 |
|
$ |
152,656 |
|
$ |
10,936 |
|
$ |
163,592 |
|
||||||
(1) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment. |
(In thousands, except percentages) | ||||||||
(Unaudited) |
||||||||
Reconciliation of Non-GAAP Amounts - Continued |
||||||||
The following tables summarize the percentage change in the 2021 results compared to the 2020 results for the corresponding periods. | ||||||||
Three Months Ended |
||||||||
Revenue | Total |
|
Foreign
|
|
Adjustments (2) |
|
Adjusted
|
|
Flavors & Extracts |
( |
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
( |
|
|
|
|
|
( |
|
( |
|
|
||
Total Revenue |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
||
Operating Income |
|
|
|
|
|
|
|
|
Flavors & Extracts |
( |
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
( |
|
|
|
|
|
( |
|
( |
|
|
||
Corporate & Other |
( |
|
|
|
( |
|
|
|
Total Operating Income |
|
|
( |
|
|
|
|
|
Diluted Earnings Per Share |
|
|
( |
|
( |
|
|
|
Adjusted EBITDA |
|
|
( |
|
N/A |
|
|
|
|
|
|
|
|
|
|
||
Year Ended |
||||||||
Revenue | Total |
|
Foreign
|
|
Adjustments (2) |
|
Adjusted
|
|
Flavors & Extracts |
( |
|
|
|
( |
|
|
|
Color |
|
|
|
|
( |
|
|
|
|
|
|
|
( |
|
|
||
Total Revenue |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
||
Operating Income |
|
|
|
|
|
|
|
|
Flavors & Extracts |
|
|
|
|
( |
|
|
|
Color |
|
|
|
|
|
|
|
|
|
|
( |
|
( |
|
|
||
Corporate & Other |
|
|
|
|
( |
|
|
|
Total Operating Income |
|
|
|
|
|
|
|
|
Diluted Earnings Per Share |
|
|
|
|
( |
|
|
|
Adjusted EBITDA |
|
|
|
|
N/A |
|
|
|
(2) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment. |
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three and twelve months ended |
||||||||||||||||||||
Three Months Ended |
|
Year Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2021 |
|
2020 |
|
% Change |
|
2021 |
|
2020 |
|
% Change |
||||||||||
Operating income (GAAP) | $ |
40,420 |
|
$ |
34,815 |
|
|
$ |
170,028 |
|
$ |
152,656 |
|
|
||||||
Depreciation and amortization |
|
13,223 |
|
|
12,810 |
|
|
|
52,051 |
|
|
49,641 |
|
|
||||||
Depreciation and amortization, divested product lines |
|
- |
|
|
(48 |
) |
|
|
(146 |
) |
|
(193 |
) |
|
||||||
Share-based compensation expense |
|
3,142 |
|
|
1,591 |
|
|
|
9,573 |
|
|
5,608 |
|
|
||||||
Divestiture & other related costs, before tax |
|
637 |
|
|
1,675 |
|
|
|
14,138 |
|
|
12,155 |
|
|
||||||
Results of operations of the divested product lines, before tax |
|
518 |
|
|
(3,415 |
) |
|
|
(1,880 |
) |
|
(7,580 |
) |
|
||||||
Operational improvement plan costs (income), before tax |
|
115 |
|
|
698 |
|
|
|
(1,895 |
) |
|
3,339 |
|
|
||||||
COVID-19 employee payment, before tax |
|
- |
|
|
3,022 |
|
|
|
- |
|
|
3,022 |
|
|
||||||
Adjusted EBITDA | $ |
58,055 |
|
$ |
51,148 |
|
|
$ |
241,869 |
|
$ |
218,648 |
|
|
||||||
The following table summarizes the reconciliation between Net cash provided by operating activities (GAAP) and Free Cash Flow for the three and twelve months ended |
||||||||||||||||||||
Three Months Ended |
|
Year Ended |
||||||||||||||||||
2021 |
|
2020 |
|
% Change |
|
2021 |
|
2020 |
|
% Change |
||||||||||
Net cash provided by operating activities (GAAP) | $ |
29,070 |
|
$ |
75,853 |
|
( |
$ |
145,218 |
|
$ |
218,780 |
|
( |
||||||
Capital expenditures |
|
(23,180 |
) |
|
(18,153 |
) |
|
|
(60,788 |
) |
|
(52,162 |
) |
|
||||||
Free Cash Flow | $ |
5,890 |
|
$ |
57,700 |
|
( |
$ |
84,430 |
|
$ |
166,618 |
|
( |
||||||
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our |
Category: Earnings
View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005725/en/
(414) 347-3706
Source:
FAQ
What were Sensient Technologies' Q4 2021 earnings?
What is Sensient Technologies' revenue growth in Q4 2021?
How did the Flavors & Extracts Group perform in Q4 2021?
What is the 2022 outlook for Sensient Technologies?